Browsing Tag
Biocon Limited
14 posts
Biocon Biologics reports positive Phase 3 results for Yesintek, biosimilar to Ustekinumab
Biocon Biologics Ltd., a global leader in biosimilar medicines and a subsidiary of India’s pioneering biopharmaceutical giant Biocon…
Biocon reports Q2FY25 revenue of Rs 3,623cr amid generics pressure
Biocon Limited, a leading global biopharmaceutical company, released its consolidated financial results for Q2FY25, reporting a total revenue…
Biocon joins forces with Tabuk Pharmaceuticals to bring GLP-1 diabetes drugs to Middle East
In a strategic move to tackle the growing diabetes crisis in the Middle East, Biocon Limited has announced…
Biocon and Biomm ink exclusive deal to bring Semaglutide to Brazil
Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing…